|
Real-time Estimate
Cboe BZX
15:38:18 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 1.175 USD | +3.07% |
|
+21.75% | -66.71% |
| 08-14 | ADC Therapeutics Balances LOTIS-5 Regulatory Risk With LOTIS-7 Opportunity, RBC Says | MT |
| 08-13 | ADC Therapeutics SA, Q2 2026 Earnings Call, Aug 13, 2026 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| ADC THERAPEUTICS SA | Bio Therapeutic Drugs | +3.07% | +21.75% | -66.71% | -62.10% | -95.97% | 146M |  |  | |
- Stock Market
- Stocks
- ADCT Stock
- Charts ADC Therapeutics SA
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
